BEIJING — China has implemented tougher supervision measures to ensure the quality of medical products amid the fight against the novel coronavirus outbreak, an official with the National Medical Products Administration said on Feb 8.

"We have strengthened supervision and inspection on businesses manufacturing supplies including biological products, antiviral drugs, medical masks, protective suits, respirators and in-vitro diagnostic reagents," Jiang Deyuan, an official with the administration, said at a press conference.

Medical product regulators have intensified oversight at the stage of product circulation to make sure that drugs and medical equipment used in epidemic control are traceable and up to standards, Jiang said.

They have also stepped up crackdowns on the manufacturing and sales of fake drugs, medical equipment and supplies, he added.